Apolipoprotein L1 (APOL1) genetic variants, particularly G1 and G2 alleles, play a pivotal role in FSGS pathogenesis, particularly among African-Americans, where 30-40% carry these risk alleles. Here, APOL1 is linked to focal segmental glomerulosclerosis.